Use of low-dose glucocorticoids and the risk of cardiovascular morbidity and mortality in rheumatoid arthritis: what is the true direction of effect?

J Rheumatol. 2005 Oct;32(10):1856-62.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Anti-Inflammatory Agents / adverse effects*
  • Arthritis, Rheumatoid* / complications
  • Arthritis, Rheumatoid* / drug therapy
  • Arthritis, Rheumatoid* / mortality
  • Cardiovascular Diseases / chemically induced*
  • Cardiovascular Diseases / epidemiology
  • Dose-Response Relationship, Drug
  • Glucocorticoids / adverse effects*
  • Humans
  • Morbidity
  • Rheumatology / methods*
  • Risk Assessment

Substances

  • Anti-Inflammatory Agents
  • Glucocorticoids